论文信息 - A Phase I-II multicenter trial with Avelumab plus autologous dendritic cell vaccine in pre-treated mismatch repair-proficient (MSS) metastatic colorectal cancer patients; GEMCAD 1602 study - 字舞流文

A Phase I-II multicenter trial with Avelumab plus autologous dendritic cell vaccine in pre-treated mismatch repair-proficient (MSS) metastatic colorectal cancer patients; GEMCAD 1602 study

C. Foguet | J. Ayuso | J. Maurel | M. Lozano | J. Cid | T. Thomson | M. Cuatrecasas | A. Ruiz-Casado | R. Cabezón | D. Benítez-Ribas | E. Pineda | M. Pagés | Á. García-Criado | L. Pedrosa | M. Español-Rego | A. Ginès | H. Oliveres | Ferrán Torres | C. Fernández‐Martos | E. Élez | Nuria Rodríguez | Marta Cascante